Zydus Lifesciences bags USFDA nod for HIV-1 drug Darunavir Ruchika Sharma15 Dec 2023 3:00 PM ISTDarunavir must be -co-administered with Ritonavir and with other antiretroviral agents.
USFDA nod to Zydus Lifesciences cancer drug Cyclophosphamide Ruchika Sharma14 Dec 2023 3:24 PM ISTCyclophosphamide is a chemotherapy medication that slows the growth of cancer cells.
Zydus Lifesciences gets USFDA okay for acquired methemoglobinemia injection Methylene Blue Ruchika Sharma6 Dec 2023 3:30 PM ISTMethylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
Zydus Lifesciences gets USFDA nod for heart failure drug Ivabradine Ruchika Sharma1 Dec 2023 2:36 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
Torrent Pharma, Zydus Lifescinces ink pact to co-market Saroglitazar Mg for chronic liver diseases in India Ruchika Sharma11 Nov 2023 2:15 PM ISTSaroglitazar Mg, is an innovative drug from Zydus approved by the DCGI to treat chronic liver diseases such as, Non-Alcoholic Steato Hepatitis (NASH)...
Zydus Lifesciences wins USFDA nod for diabetes drug Zituvimet Ruchika Sharma6 Nov 2023 11:34 AM ISTThe approval of ZITUVIMET is based on research, development, regulatory, and manufacturing work performed by Zydus teams.
Zydus Lifesciences, Lupin to co-market Saroglitazar Mg for chronic liver diseases treatment in India Ruchika Sharma3 Nov 2023 3:30 PM ISTUnder the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
Zydus, Guardant Health to co-promote Guardant360 portfolio of liquid, tissue biopsy tests across India, Nepal Ruchika Sharma2 Nov 2023 3:30 PM ISTGuardant360 is a minimally invasive liquid biopsy test that provides comprehensive genomic profiling of all solid tumours by analysing circulating...
Zydus Lifesciences buys LiqMeds Group for around Rs 689 crore Ruchika Sharma1 Nov 2023 4:45 PM ISTZydus will pay an upfront consideration of GBP 68 million (around Rs 689 crore) and yearly earn-outs until 2026 depending on achievement of certain...
Zydus Lifesciences gets CDSCO nod to begin Phase II clinical trial of ZYIL1 in Amyotrophic Lateral Sclerosis patients Ruchika Sharma25 Oct 2023 11:16 AM ISTThe Phase II clinical trial will study safety, tolerability, pharmacokinetics and pharmacodynamics in patients with ALS.
Zydus Lifesciences bags USFDA approval for type 2 diabetes mellitus drug Zituvio for adults Ruchika Sharma21 Oct 2023 11:19 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA)...
Zydus ropes in Punit Patel as President, CEO to lead business operations in North America Ruchika Sharma16 Oct 2023 11:10 AM ISTAhmedabad: Zydus Lifesciences Limited, a discovery-driven, global lifesciences company has announced the appointment of Punit Patel as President and...
